MedTrace Logo

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

NCT01846195 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2022-11-09

Study results available
· View outcomes & findings →

Summary

Non-invasive monitoring to measure changes in blood volume.

Conditions

  • Blood Loss

Interventions

DEVICE

CM 1500

Sponsors & Collaborators

  • DTarget

    collaborator UNKNOWN

  • Zynex Monitoring Solutions

    lead INDUSTRY

Principal Investigators

  • John Ziegler, MD · Premier Research Group plc

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-06
Primary Completion
2013-03-20
Completion
2013-03-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01846195 on ClinicalTrials.gov